NASDAQ:ARTL - Artelo Biosciences Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $7.00
  • Forecasted Upside: 593.07 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$1.01
▼ -0.04 (-3.81%)

This chart shows the closing price for ARTL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Artelo Biosciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARTL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARTL

Analyst Price Target is $7.00
▲ +593.07% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Artelo Biosciences in the last 3 months. The average price target is $7.00, with a high forecast of $7.00 and a low forecast of $7.00. The average price target represents a 593.07% upside from the last price of $1.01.

This chart shows the closing price for ARTL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in Artelo Biosciences. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/25/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/24/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/19/2021LADENBURG THALM/SH SHReiterated RatingBuy$7.00Low
2/12/2021LADENBURG THALM/SH SHInitiated CoverageBuy$7.00Low
1/7/2021Maxim GroupUpgradeHold ➝ BuyN/A
5/13/2020Maxim GroupDowngradeBuy ➝ HoldLow
11/20/2019Maxim GroupReiterated RatingBuy$8.00Low
7/9/2019Maxim GroupInitiated CoverageBuy$8.00High
(Data available from 7/25/2016 forward)
Artelo Biosciences logo
Artelo Biosciences, Inc. is a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system. The company was founded by James Manley on May 2, 2011 and is headquartered in Solana Beach, CA.
Read More

Today's Range

Now: $1.01
Low: $1.00
High: $1.05

50 Day Range

MA: $1.16
Low: $1.00
High: $1.29

52 Week Range

Now: $1.01
Low: $0.45
High: $3.67

Volume

226,806 shs

Average Volume

328,074 shs

Market Capitalization

$24.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.29

Frequently Asked Questions

What sell-side analysts currently cover shares of Artelo Biosciences?

The following Wall Street research analysts have issued stock ratings on Artelo Biosciences in the last twelve months: LADENBURG THALM/SH SH, Maxim Group, and Zacks Investment Research.
View the latest analyst ratings for ARTL.

What is the current price target for Artelo Biosciences?

1 Wall Street analysts have set twelve-month price targets for Artelo Biosciences in the last year. Their average twelve-month price target is $7.00, suggesting a possible upside of 593.1%. LADENBURG THALM/SH SH has the highest price target set, predicting ARTL will reach $7.00 in the next twelve months. LADENBURG THALM/SH SH has the lowest price target set, forecasting a price of $7.00 for Artelo Biosciences in the next year.
View the latest price targets for ARTL.

What is the current consensus analyst rating for Artelo Biosciences?

Artelo Biosciences currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ARTL will outperform the market and that investors should add to their positions of Artelo Biosciences.
View the latest ratings for ARTL.

What other companies compete with Artelo Biosciences?

How do I contact Artelo Biosciences' investor relations team?

Artelo Biosciences' physical mailing address is 888 Prospect Street Suite 210, La Jolla CA, 92037. The company's listed phone number is (760) 943-1689 and its investor relations email address is [email protected] The official website for Artelo Biosciences is www.artelobio.com.